• Emre Ozdemir, Ozgen Safak, Mert Pehlivan AltIn, Didar Elif Akgun, SadIk Volkan Emren, Eyup AvcI, Mehmet Tokac, and Filiz Akcay AkyIldIz.
• Cardiology Clinic, Izmir Katip Çelebi University, Ataturk Education and Research Hospital, Izmir, Turkey.
• J Coll Physicians Surg Pak. 2020 Mar 1; 30 (3): 235-239.

ObjectiveTo evaluate the efficacy of the monocyte/lymphocyte, platelet/lymphocyte, and HDL/LDL ratios as markers of the severity of coronary artery ectasia(CE).Study DesignCross-sectional study.Place And Duration Of StudyDepartment of Cardiology, Izmir Katip Celebi University and Balikesir University, Turkey, from January 2017 to October 2018.MethodologyA total of 7,923 coronary angiographs were retrospectively scanned. Inclusion criteria was >1.5 times dilatated of native coronary artery segment. Exclusion criteria was <1.5 times or no dilatation of native coronary segment compared with normal coronary segment. Demographic features, CE type, clinic status, monocyte/lymphocyte, platelet/ lymphocyte and HDL/LDL ratios are collected.ResultsTwo hundred and six (2.6%) cases were identified, which had a mean age of 61.4 ±11.4 years. The male to female ratio was 3:1; and 46% of the patients presented with unstable angina. The prevalence of CE was 2.6%; and 118 (57.2%) patients had non-obstructive coronary artery disease. Hypertension, hyperlipidemia and smoking were the most commonly seen disorders. Markis Type 4 was the most common type of CE determined. A statistically significant correlation was determined among the monocyte/lymphocyte ratio, platelet/lymphocyte ratio, and the increased diameter of ectasia of the vessel.ConclusionAlthough there should be awareness of CE, many clinicians do not pay as much attention to CE as to coronary stenosis. The results of this study showed that the monocyte/lymphocyte ratio and platelet/lymphocyte ratio are consistent with the ectasia severity. This correlation will be useful for the evaluation of follow-up and treatment success in patients with CE.

22 keywords...

hide…